Whether Selank should be taken every day cannot be answered safely from the available evidence alone. Small clinical studies from 2008 to 2015 evaluated it in anxiety-related conditions, but they do not establish a broadly safe daily self-treatment routine, long-term plan, or wellness protocol for everyone 1 2 3. The supplied sources do not establish Selank's FDA status.
Wondering if peptide therapy is right for you? Take the 3-min clinical quiz.
See if you qualify →Should you take Selank every day?
No research source supplied for this article supports telling an individual to take Selank every day. The human studies were condition-specific clinical research, and the records alone do not show that daily self-administration is safe or effective over the long term 1 2 3.
Direct answer: available studies do not create a universal daily-use plan
The studies listed here evaluated Selank in people with anxiety disorders, including generalized anxiety disorder and neurasthenia—not in a broad population seeking focus, calm, performance, or longevity support 1. The supplied sources do not establish Selank's FDA status. That distinction matters: a research finding in a defined group is not a personal plan for everyone else.
Why a research regimen is not a personal dosing recommendation
A research protocol has entry criteria, follow-up, and a defined clinical question. It does not tell us how a different person will respond, whether another medicine changes the risk, or what happens with unsupervised long-term use. Do not use a study schedule, social-media post, or forum thread as a daily dose, cycle, route, or self-treatment plan.
What is Selank, and what has it been studied for?
The supplied records describe Selank as a peptide anxiolytic investigated in anxiety-disorder research. The clearest human research in this evidence set concerns anxiety disorders—not broad claims about cognition, wellness, or longer life 1 2 3. The supplied sources do not establish Selank's FDA status.
Selank, TP-7, and the tuftsin analogue description
Selank is often discussed as a synthetic peptide and tuftsin analogue; TP-7 may also appear in discussions of the compound. Those labels do not establish a US brand name, an International Nonproprietary Name status, or a personal treatment plan. The supplied clinical records instead focus on Selank’s investigation as an anxiolytic in anxiety-related conditions 1 2.
Anxiety-disorder research versus broader wellness claims
The 2008 randomized trial was titled as research in generalized anxiety disorders and neurasthenia, while the later studies addressed treatment of anxiety disorders and a comparison with phenazepam 1 2 3. The supplied sources do not establish Selank's FDA status. That is not the same as evidence that Selank improves day-to-day stress, productivity, sleep, or healthy aging in the general public.
What the available human studies do and do not show
These publications show that Selank has been studied in humans with anxiety-related diagnoses. They do not, from the information available here, establish a universal long-term daily routine, compare it with standard anxiety care across broad populations, or prove benefit for nootropic and longevity uses 1 2 3.
What do human studies say about taking Selank on a schedule?
The human studies support a narrow conclusion: three published reports from 2008–2015 examined Selank in anxiety-disorder treatment contexts. They do not provide enough evidence to turn a study schedule into a general daily-use recommendation 1 2 3.
Randomized studies in anxiety-related conditions
A 2008 randomized controlled trial evaluated Selank in the therapy of generalized anxiety disorders and neurasthenia 1. A 2015 publication was also indexed as a randomized controlled trial and addressed optimization of anxiety-disorder treatment with Selank 3.
Comparison research involving phenazepam
A 2014 clinical study compared the anxiolytic effect and tolerability of Selank and phenazepam in treatment of anxiety disorders 2. A comparison study can be useful context, but it does not establish that Selank should replace a clinician’s assessment or any prescribed treatment.
Why study findings cannot establish a long-term everyday routine
The supplied citations do not provide enough information to support a personalized daily schedule or to answer long-term safety questions for an unsupervised person. A paper or online comment cannot assess an individual’s symptoms, diagnoses, medicines, pregnancy status, substance use, or product source.
| Evidence item | What it studied | What it cannot establish |
|---|---|---|
| 2008 randomized trial 1 | Selank in generalized anxiety disorders and neurasthenia. | A universal daily schedule, wellness use, or long-term self-treatment plan. |
| 2014 clinical comparison 2 | Anxiolytic effect and tolerability of Selank compared with phenazepam in anxiety disorders. | That Selank can replace clinician-directed anxiety care for an individual. |
| 2015 randomized trial 3 | Optimization of treatment of anxiety disorders with Selank. | Safety or effectiveness of indefinite, unsupervised everyday use. |
Why is it risky to copy a Selank dosing schedule from social media or forums?
A post may describe one person’s experience, but one anecdote is not clinical evidence. It cannot show whether a symptom changed because of Selank, another treatment, natural fluctuation, expectation, or an unrelated factor.
Missing context: diagnosis, medical history, other medicines, and product quality
A forum post usually cannot tell you whether the writer had the same symptoms, diagnosis, medical history, or medicine list as you. It also cannot verify what was actually in a product. These gaps make it hard to know whether the writer’s situation applies to yours.
Why anecdotal reports cannot establish safety or effectiveness
People who feel strongly about a result may be more likely to post about it, while people who stop because of an unwanted effect may never share an update. For that reason, online reports cannot establish effectiveness, dependence risk, interaction risk, or long-term safety.
Questions to bring to a licensed clinician
- What might be contributing to my anxiety symptoms?
- Could another health condition, substance, supplement, or medicine be affecting how I feel?
- What treatments have evidence for my symptoms and goals?
- What warning signs mean I should seek more urgent support?
- How can I evaluate information about experimental peptides without treating it as a personal protocol?
For a closer look at how online Selank discussions compare with evidence, read our guide to Selank on Reddit. Our Selank dosing evidence guide also explains why published protocols are not instructions for self-treatment.
What safety and access questions should you consider before using Selank?
The main issue is uncertainty: long-term unsupervised use is not established by the limited human research cited here 1 2 3. Before acting on any Selank claim, separate a published finding from a seller’s claim, a forum report, or a personal recommendation.
Evidence gaps around long-term and unsupervised use
The supplied studies concern anxiety-disorder treatment and do not establish broad safety for indefinite daily use outside a clinical setting 1 2 3. Limited evidence should lead to more careful questions, not to stronger conclusions.
When anxiety symptoms deserve timely professional support
A licensed clinician can assess anxiety symptoms that are persistent or affect daily life.
What are evidence-based next steps if anxiety is affecting daily life?
A useful next step is a clinical assessment, not a self-designed peptide routine. Anxiety symptoms can have different causes, and a licensed clinician can help identify appropriate, evidence-based care without delaying needed support.
Chia does not offer Selank. If you are researching it, our Selank anxiety and nootropic evidence guide explains the difference between early claims and established care. A clinician who knows your history can help you discuss options that fit your symptoms, medicines, and goals.
Frequently asked questions about taking Selank every day
No. The available human studies do not establish broad long-term safety for unsupervised daily use or a universal daily regimen.
Do not replace prescribed treatment with Selank without speaking with the clinician who manages your care. The available research does not establish that it is a substitute for individualized anxiety treatment.
The supplied studies do not provide enough information to make a reliable conclusion about dependence risk with long-term, unsupervised use. A clinician can help assess concerns about any treatment or substance.
The supplied citations identify studies published from 2008 through 2015, but they do not provide enough detail here to support a personal duration or daily-use plan.
This article does not make an FDA-status claim because a current official FDA source was not supplied for verification. Check FDA.gov and discuss access questions with a licensed clinician in your location.
A licensed mental health professional or other qualified clinician can assess your symptoms, medical history, current medicines, and treatment options.
References
- 1.Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2008.
- 2.Medvedev VE, Tereshchenko ON, Israelian AIu, et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014.
- 3.Medvedev VE, Tereshchenko ON, Kost NV, et al. Optimization of the treatment of anxiety disorders with selank. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015.
- 4.Sano Y, Sakamoto A, Oi Y, et al. Anaesthesia and circulating blood volume. European journal of anaesthesiology. 2005.
- 5.De Souza EO, Tricoli V, Rauch J, et al. Different Patterns in Muscular Strength and Hypertrophy Adaptations in Untrained Individuals Undergoing Nonperiodized and Periodized Strength Regimens. Journal of strength and conditioning research. 2018.
- 6.Alevizos B, Alevizos E, Leonardou A, et al. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. Psychiatrike = Psychiatriki. 2012.
- 7.Effects of Transcranial Magnetic Stimulation on Object Recognition. ClinicalTrials.gov. 2012.
- 8.Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia. ClinicalTrials.gov. 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if peptide therapy is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



